Hemas Holdings PLC (HHL) - 2Q FY25 - BUY
Earnings Reviews
03/12/2024
118
0
We maintain our BUY rating with an intrinsic value of LKR 113 based on SOTP valuation. We remain bullish on HHL’s Healthcare sector in the near to medium term while a recovery in Consumer Brands is expected with improved consumer spending.
You must login to post a comment.